Summary
The council took first reading on up to $1.4 million in bonds to buy the 103 Maine Avenue property — tied to a disputed right of first refusal involving Northeast Pain Management's hoped-for purchase. Residents demanded a cost-benefit analysis and answers before Finance Committee review Sept. 21.
At a glance
- Total mentions
- 5
- Last 30 days
- 1
Rising — discussed at 3 meetings since Sep 14, 2026, up from 0 in the two months before.
Impact analysis
Up to $1.4 million in bonds, with a tax levy to cover principal and interest.
Depends on the city's intent — medical providers wanted the building for expanded pain management and primary care.
Taxpayers facing rising rates who may carry the debt service; Northeast Pain Management loses its chance to buy the property.
Mentions & discussions (4)
Finance Committee (Regular) - Oct 5, 2026
Bangor still hasn't finished its overdue audit, which blocks the city from bonding competitively. The city manager says December is hopeful, January reasonable, and extra staffing is being considered to catch up.
City Council (Regular) - Sep 28, 2026
The council authorized $1.4 million in bonds to buy the 103 Maine Avenue building so the public health department can expand, displacing a tenant business in the process.
City Council (Regular) - Sep 14, 2026
The council took first reading on up to $1.4 million in bonds to buy the 103 Maine Avenue property — tied to a disputed right of first refusal involving Northeast Pain Management's hoped-for purchase. Residents demanded a cost-benefit analysis and answers before Finance Committee review Sept. 21.
City Council (Regular) - May 27, 2026
The council gave the Bangor Housing Authority 90 more days on its land option to build housing for formerly homeless residents needing 24-hour care due to mental illness or addiction — a concrete step in the city's 2026 housing goal.
We'll email you when it's on an upcoming agenda and when it's voted on, at most once a day.
The weekly brief for Bangor
What the council decided, in plain English — one email a week.
Free. Unsubscribe with one click any time. We never sell your email.